We established a human T-lymphoblast cell line (Mo) that produces factors stimulating the proliferation of hematopoietic cells. These include a colony-stimulating factor for normal human granulocytes and macrophages, and a factor with erythroid-potentiating activity (EPA) that enhances the proliferation of normal human erythroid progenitors in vitro. Erythroid-potentiating activity has been partially purified and characterized. It is an acidic glycoprotein of 45,000 daltons molecular weight and it has remarkable heat stability. Erythroid-potentiating activity is physically separable from the colony-stimulating factor. Partially purified EPA was found to stimulate the proliferation of human K-562 and murine Friend erythroleukemia cells. These erythroleukemia cell lines may therefore prove useful for studying the action of EPA on target cells. Erythroid-potentiating factors from other human and murine sources stimulated erythroleukemia cell proliferation in a manner indicating some species restriction. Purification and structural analysis of the EPA molecule will ultimately be required in order to determine the details of its biologic action and to define its relationship to other erythropoietic factors.
Download full-text PDF |
Source |
---|
Platelets
June 2007
First Department of Internal Medicine, Department of Medical Technology, Nagoya University School of Medicine, Nagoya, Japan.
The extracellular matrix (ECM), the product of stromal cells, is now thought to make a dynamic network in tissues. Stromal cells can support other cells not only by direct contact but also via this ECM network. The regulated turnover and remodeling of ECM needs both ECM degrading enzymes named matrix metalloproteinases (MMPs) and their inhibitors called tissue inhibitors of metalloproteinases (TIMPs).
View Article and Find Full Text PDFCytokine
August 1998
Centre de Génétique Moléculaire et Cellulaire, UMR 5534 CNRS, Université Claude Bernard Lyon I, Villeurbanne, France.
The burst formation from human and murine burst forming unit-erythroid (BFU-E) requires the presence of erythropoietin (Epo) in semi-solid cultures of bone marrow cells. A number of haematopoietic factors are described that increase the burst number: interleukin 3 (IL-3), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-9, IL-11, insulin-like growth factor I, and erythroid potentiating activity (EPA). The authors now show that another activity present in medium conditioned from adult or fetal human kidney cells specifically stimulates the proliferation of BFU-E.
View Article and Find Full Text PDFInt J Cancer
January 1998
Tumor Biology and Carcinogenesis Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
The tissue inhibitor of metalloproteinases-1 (TIMP-1) has at least 2 independent functions, i.e., regulation of matrix metalloproteinases and erythroid-potentiating activity.
View Article and Find Full Text PDFInt J Cancer
April 1996
Tumor Biology and Carcinogenesis Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA.
Tissue inhibitor of metalloproteinases-1 (TIMP-1) is known to have at least 2 distinct types of activity, i.e., as a regulator of collagenolytic activity, and erythroid potentiating activity (EPA).
View Article and Find Full Text PDFBlood
December 1995
Department of Pathology, Northwestern University Medical School, Chicago, IL 60611, USA.
Tissue inhibitor of metalloproteinases-1 (TIMP-1), the major physiological matrix metalloproteinase inhibitor and a potent antimetastatic factor, also stimulates the growth of erythroid progenitors (erythroid-potentiating activity). We analyzed the relationship between the growth factor activity and protease inhibition by preparing purified TIMP-1 "knockout" proteins lacking in vitro antiproteolytic activity. The growth-stimulatory effect of these N-terminal TIMP-1 point mutants, as tested in an in vitro assay using erythroid precursors (erythroid burst-forming units) was equal to that of unmutated TIMP-1.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!